Reverse Trigger Phenotypification and Response to Ventilatory Adjustments (RT-CHASERS)

December 9, 2023 updated by: Miguel Á Ibarra-Estrada, Hospital Civil de Guadalajara

Incidence of Reverse Trigger Phenotypes and Response to Ventilatory Adjustments in Patients With ARDS

The goal of this prospective observational study is to describe the incidence of reverse trigger (RT) in mechanically ventilated patients with diagnosis of acute respiratory distress syndrome (ARDS).

The main questions it aims to answer are:

  • Real incidence of RT based on continuous monitoring
  • The response to mechanical ventilatiory adjustments Participants will be included as soon as neuromuscular blockers (NMB)/sedation is stopped or in case of spontaneous respiratory efforts detection, whatever happens first. Continuous monitoring will be performed by esophageal manometry until switch to a pressure support (spontaneous) mode, restart of deep sedation/neuromuscular blockers by medical indication, or death.

In order to allow detection of possible RT in patients with ongoing sedation/NMB, mechanical ventilator waveforms will be screened every 1-2 hours by investigators and critical care physicians with at least 1 year of specific training in detection of dyssynchronies.

Study Overview

Detailed Description

Measurements:

An esophageal catheter for manometry will be placed as usual practice with confirmation of adequate position with the Baydur's occlusion test before recordings. An independent flow sensor and pressure transducer will be placed and connected to a laptop computer to obtain real-time monitoring along with continuous recordings, which then will be off-line analyzed by two experts, for confirmation of RT and characterization.

Data collection:

Main cause of the acute respiratory failure and days on mechanical ventilation until enrollment will be collected as well as demographic characteristics, including APACHE II, SOFA and the previous requirement of prone positioning therapy.

At identification of the RT, drugs for sedation and analgesia, time from initiation of mechanical ventilation to RT identification and blood gas analysis will be recorded. Ventilatory settings will also be collected, including the control variable of the ventilatory mode (volume or pressure), respiratory rate, received tidal volume in ml/kg of predicted body weight, maximum inspiratory flow, ratio of partial arterial oxygen pressure (pO2) to fraction of inspired oxygen (FiO2), driving pressure and (positive end-expiratory pressure (PEEP). Data about esophageal pressure related to RT will also be recorded, including the magnitude of pressure swing, phase angle, coefficient of variation, RT phenotype, entrainment ratio and the presence of breath stacking.

Patient-centered outcomes including length of mechanical ventilation, intensive care and hospital length of stay, and mortality will be followed-up until 60 days.

Study Type

Observational

Enrollment (Estimated)

130

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Guadalajara, Mexico, 44280
        • Recruiting
        • Hospital Civil Fray Antonio Alcalde
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Quetzalcóatl Chávez-Peña, MD
        • Sub-Investigator:
          • Arnulfo López-Pulgarín, MD
        • Sub-Investigator:
          • Guadalupe Aguirre-Avalos, PhD
        • Principal Investigator:
          • Miguel Ibarra-Estrada, MD
        • Sub-Investigator:
          • David Hernández-Lugo, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Mechanically ventilated patients with acute respiratory distress syndrome.

Description

Inclusion Criteria:

  • Diagnosis of ARDS according to the Berlin criteria and added New Global Definition 2023
  • Mechanical ventilation

Exclusion Criteria:

  • <18 years
  • Tracheostomy status
  • Pneumothorax
  • Tube thoracostomy with air leaks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of reverse trigger
Time Frame: 60 days
Proportion of patients who developed reverse trigger
60 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Days of mechanical ventilation
Time Frame: 60 days
Days of mechanical ventilation
60 days
ICU length of stay
Time Frame: 60 days
Days from ICU admission to discharge to wards
60 days
Mortality
Time Frame: 60 days
Rate of deceased patients in percentage
60 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of RT
Time Frame: 60 days
Total time of presence of RT
60 days
Phenotypes of RT
Time Frame: 60 days
Rate of the different phenotypes according to cycle initiation and termination of patient's respiratory effort
60 days
Intensity of breathing efforts
Time Frame: 60 days
Intensity of respiratory efforts as measured by esophageal manometry
60 days
Response to ventilatory adjustments
Time Frame: 60 days
Change in RT characteristics after changing ventilatory settings
60 days
Association with severity
Time Frame: 60 days
Association of RT with lung disease severity as measured by pO2:FiO2 ratio
60 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Miguel Ibarra Estrada, MD, Hospital Civil Fray Antonio Alcalde

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 17, 2023

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

November 19, 2023

First Submitted That Met QC Criteria

November 19, 2023

First Posted (Actual)

November 28, 2023

Study Record Updates

Last Update Posted (Estimated)

December 15, 2023

Last Update Submitted That Met QC Criteria

December 9, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

3
Subscribe